Discovery and Characterization of Pure RhIR Antagonists against Pseudomonas aeruginosa Infections
- Authors
- Nam, SangJin; Ham, So-Young; Kwon, Hongmok; Kim, Han-Shin; Moon, Suhyun; Lee, Jeong-Hoon; Lim, Taehyeong; Son, Sang-Hyun; Park, Hee-Deung; Byun, Youngjoo
- Issue Date
- Aug-2020
- Publisher
- American Chemical Society
- Citation
- Journal of Medicinal Chemistry, v.63, no.15, pp 8388 - 8407
- Pages
- 20
- Indexed
- SCIE
SCOPUS
- Journal Title
- Journal of Medicinal Chemistry
- Volume
- 63
- Number
- 15
- Start Page
- 8388
- End Page
- 8407
- URI
- https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/33648
- DOI
- 10.1021/acs.jmedchem.0c00630
- ISSN
- 0022-2623
- Abstract
- Pseudomonas aeruginosa (P. aeruginosa) is an opportunistic human pathogen that forms biofilms and produces virulence factors via quorum sensing (QS). Blocking the QS system in P. aeruginosa is an excellent strategy to reduce biofilm formation and the production of virulence factors. RhIR plays an essential role in the QS system of P. aeruginosa. We synthesized 55 analogues based on the chemical structure of 4-gingerol and evaluated their RhIR inhibitory activities using the cell-based reporter strain assay. Comprehensive structure-activity relationship studies identified the alkynyl ketone 30 as the most potent RhIR antagonist. This compound displayed selective RhIR antagonism over LasR and PqsR, strong inhibition of biofilm formation, and reduced production of virulence factors in P. aeruginosa. Furthermore, the survival rate of Tenebrio molitor larvae treated with 30 in 30, a pure RhIR antagonist, can be utilized for developing QS-modulating molecules vivo greatly improved. Therefore, compound in the control of P. aeruginosa infections.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 2. Clinical Science > Department of Radiology > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.